Multicentric survey on dose reduction/interruption of cancer drug therapy in 12.472 patients: indicators of suspected adverse reactions

Antiblastic drugs have a high number of potential side-effects. Paradoxically, according to the National Network of Pharmacovigilance, the number of reported adverse reactions to these agents is proportionally lower than that registered for non antiblastic drugs. Critical phenomena such as treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Gardini, Andrea Casadei, Tenti, Elena, Masini, Carla, Nanni, Oriana, Scarpi, Emanuela, Valgiusti, Martina, Restuccia, Silvia, Gallani, Maria Laura, Palazzini, Simonetta, Bianchini, Erica, Menozzi, Silvia, Maugeri, Antonio, Amadori, Dino, Minguzzi, Martina, Frassineti, Giovanni Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130038/
https://www.ncbi.nlm.nih.gov/pubmed/27119511
http://dx.doi.org/10.18632/oncotarget.8942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130038/
https://www.ncbi.nlm.nih.gov/pubmed/27119511
http://dx.doi.org/10.18632/oncotarget.8942

Ejemplares similares